The contribution of MRCK to tumor cell invasion was examined by knocking down both MRCKα and MRCKβ in MB 231 breast cancer cells and determining the effects in a 3-dimensional inverse matrigel invasion assay [25]. Here, CDC42BPB is linked to breast cancer.